- Home
- PKBK vs ABEO Comparison
PKBK vs ABEO Comparison
Compare PKBK & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PKBK
- ABEO
- Stock Information
- Founded
- PKBK 1999
- ABEO N/A
- Country
- PKBK United States
- ABEO United States
- Employees
- PKBK N/A
- ABEO N/A
- Industry
- PKBK Major Banks
- ABEO Biotechnology: Pharmaceutical Preparations
- Sector
- PKBK Finance
- ABEO Health Care
- Exchange
- PKBK Nasdaq
- ABEO Nasdaq
- Market Cap
- PKBK 249.7M
- ABEO 247.8M
- IPO Year
- PKBK N/A
- ABEO 1980
- Fundamental
- Price
- PKBK $20.91
- ABEO $5.70
- Analyst Decision
- PKBK
- ABEO Strong Buy
- Analyst Count
- PKBK 0
- ABEO 3
- Target Price
- PKBK N/A
- ABEO $18.00
- AVG Volume (30 Days)
- PKBK 33.3K
- ABEO 225.2K
- Earning Date
- PKBK 01-22-2025
- ABEO 11-14-2024
- Dividend Yield
- PKBK 3.43%
- ABEO N/A
- EPS Growth
- PKBK N/A
- ABEO N/A
- EPS
- PKBK 2.33
- ABEO N/A
- Revenue
- PKBK $63,152,000.00
- ABEO N/A
- Revenue This Year
- PKBK N/A
- ABEO N/A
- Revenue Next Year
- PKBK N/A
- ABEO $18,714.71
- P/E Ratio
- PKBK $8.94
- ABEO N/A
- Revenue Growth
- PKBK N/A
- ABEO 147.52
- 52 Week Low
- PKBK $15.24
- ABEO $3.05
- 52 Week High
- PKBK $24.29
- ABEO $9.01
- Technical
- Relative Strength Index (RSI)
- PKBK 28.63
- ABEO 34.30
- Support Level
- PKBK $21.90
- ABEO $5.45
- Resistance Level
- PKBK $22.75
- ABEO $6.04
- Average True Range (ATR)
- PKBK 0.52
- ABEO 0.19
- MACD
- PKBK -0.29
- ABEO -0.04
- Stochastic Oscillator
- PKBK 13.12
- ABEO 19.47
About PKBK Parke Bancorp Inc.
Parke Bancorp Inc operates as a commercial bank providing personal and financial services to individuals and small to mid-sized businesses in various states of the USA. The bank offers services such as loan products, deposit services, and other financial products through its retail branches and other channels to its customers. Its lending businesses are commercial real estate lending, residential real estate lending, and construction lending among others. The Company operates one reportable segment of business, community banking.
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel AIM.